Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Sydney,
- Most recent report
- 6-K, filed Nov 2, 2026
- Incorporated
- N/A
- Filings on record
- 739 filings
- On EDGAR
- CIK 1506184
- Fiscal year ends
- June
- Filer status
- Accelerated filer
Financials 8 of 674
- 6-K Report a foreign issuer made public elsewhere Nov 2, 2026
- 6-K Report a foreign issuer made public elsewhere Oct 29, 2026
- 20-F Annual report, foreign issuer Oct 23, 2026
- 6-K Report a foreign issuer made public elsewhere Oct 14, 2026
- 6-K Report a foreign issuer made public elsewhere Sep 22, 2026
- 6-K Report a foreign issuer made public elsewhere Sep 11, 2026
- 6-K Report a foreign issuer made public elsewhere Sep 2, 2026
- 6-K Report a foreign issuer made public elsewhere Aug 3, 2026
Prospectuses and Registrations 8 of 10
Ownership 8 of 15
- 3 Insider reported their initial holding Apr 16, 2026
- 3 Insider reported their initial holding Apr 13, 2026
- 3 Insider reported their initial holding Apr 13, 2026
- 3 Insider reported their initial holding Apr 7, 2026
- 3 Insider reported their initial holding Apr 1, 2026
- 3 Insider reported their initial holding Apr 1, 2026
- 3 Insider reported their initial holding Apr 1, 2026
- 3 Insider reported their initial holding Apr 1, 2026
Other 8 of 40
- UPLOAD Comment letter from SEC staff May 11, 2026
- CORRESP Reply to SEC staff Apr 24, 2026
- UPLOAD Comment letter from SEC staff Apr 7, 2026
- EFFECT Notice that a registration became effective May 5, 2023
- CORRESP Reply to SEC staff May 3, 2023
- UPLOAD Comment letter from SEC staff May 2, 2023
- EFFECT Notice that a registration became effective Oct 30, 2019
- CORRESP Reply to SEC staff Oct 28, 2019
Everything here comes from IMMUTEP Ltd's own filings on SEC EDGAR. The filing list is rechecked every hour.